|
|
Volumn 103, Issue 10, 2011, Pages 786-787
|
|
AACR highlights: Promise for treating pancreatic cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERLOTINIB;
GEMCITABINE;
K RAS PROTEIN;
LAPATINIB;
NANOPARTICLE;
PACLITAXEL;
TRASTUZUMAB;
VISMODEGIB;
ALBUMIN BOUND PACLITAXEL;
ALBUMIN-BOUND PACLITAXEL;
ALBUMINOID;
ANILIDE;
ANTINEOPLASTIC AGENT;
CHLOROQUINE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
PYRIDINE DERIVATIVE;
TRANSCRIPTION FACTOR;
TRIM29 PROTEIN, MOUSE;
AUTOPHAGY;
BIOTYPE;
CANCER CELL;
CANCER SURVIVAL;
CLINICAL RESEARCH;
DRUG DELIVERY SYSTEM;
DRUG RESEARCH;
GENE MUTATION;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL LITERATURE;
MEDICAL SOCIETY;
NOTE;
PANCREAS CANCER;
PRIORITY JOURNAL;
SURVIVAL RATE;
ANIMAL;
CLINICAL TRIAL (TOPIC);
DELAYED DIAGNOSIS;
DISEASE COURSE;
DRUG EFFECT;
GENETICS;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
MOUSE;
MUTATION;
OFF LABEL DRUG USE;
ONCOGENE RAS;
PANCREAS TUMOR;
SIGNAL TRANSDUCTION;
UNITED STATES;
ALBUMINS;
ANILIDES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AUTOPHAGY;
CHLOROQUINE;
CLINICAL TRIALS AS TOPIC;
DELAYED DIAGNOSIS;
DEOXYCYTIDINE;
DISEASE PROGRESSION;
GENES, RAS;
HUMANS;
MICE;
MOLECULAR TARGETED THERAPY;
MUTATION;
OFF-LABEL USE;
PACLITAXEL;
PANCREATIC NEOPLASMS;
PYRIDINES;
SIGNAL TRANSDUCTION;
TRANSCRIPTION FACTORS;
UNITED STATES;
|
|
EID: 79960616183
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djr183 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
